Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study
- PMID: 30100561
- DOI: 10.1136/annrheumdis-2017-212515
Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study
Abstract
Autoinflammatory diseases (AIDs) are a relatively new family of disorders, defined about 19 years ago. Some of them are hereditary and some are not. The names given to these diseases do not follow any systematic guidelines, and sometimes the same disorder carries several names. The aim of this study is to refine the definition of AIDs and to provide some conventions for their naming. We focused mainly on monogenetic AIDs. Delphi technique, which enables consensus among a group of experts through internet and mail communication and questionnaires, was employed. After achieving 100% consensus among six members of a steering committee, the questionnaire containing AID definitions and the agreed-upon conventions were sent to 26 physicians and researchers working in the field of AIDs in order to gain broader support for the committee's proposals. The committee proposed the following definition for AIDs: "Autoinflammatory diseases are clinical disorders caused by defect(s) or dysregulation of the innate immune system, characterized by recurrent or continuous inflammation (elevated acute phase reactants-APR) and the lack of a primary pathogenic role for the adaptive immune system (autoreactive T-cells or autoantibody production)." Several rules were defined for guiding the naming of these diseases among which are: abandoning eponyms and preferring the name of the gene over its encoded protein. The new definition for AIDs allows inclusion of clinical disorders mainly associated with defects in the innate immune system. The new conventions propose names with clinical meaning and in some cases even clues for treatment.
Keywords: autoimmune diseases; familial mediterranean fever; fever syndromes; inflammation.
© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: For EB-C, MG, AG, DLK, HJL, IT: Nothing to disclose for this manuscript. NR received honoraria for consultancy of speaker’s bureau from the following pharmaceutical companies since last 5 years: Abbott, AbbVie, Amgen, Biogenidec, Astellas, Alter, AstraZeneca, Baxalta Biosimilars, Boehringer, BMS, CD Pharma, Celgene, CrescendoBio, EMD Serono, Hoffman La Roche, Italfarmaco, Janssen, MedImmune, Medac, Novartis, Novo Nordisk, Pfizer, Rewind Arms, R Pharma, Sanofi Aventis, Servier, Sinergie, Takeda, Vertex, UCB Biosciences GmbH. The Gaslini Hospital, which is the public Hospital where NR works as full time public employee, has received contributions from the following industries: Abbott, BMS, ‘Francesco Angelini’, GlaxoSmithKline (GSK), Hoffman La Roche, Italfarmaco, Janssen, Novartis, Pfizer, Sanofi Aventis, Schwarz Biosciences, Sobi, Xoma, Wyeth. This money has been reinvested for the research activities of the hospital in a fully independent manner without any commitment with third parties.
Similar articles
-
Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature.J Med Genet. 2013 Jun;50(6):349-59. doi: 10.1136/jmedgenet-2013-101577. Epub 2013 Mar 27. J Med Genet. 2013. PMID: 23536687 Review.
-
Clinical and biochemical landmarks in systemic autoinflammatory diseases.Ann Med. 2012 Nov;44(7):664-73. doi: 10.3109/07853890.2011.598546. Epub 2011 Oct 5. Ann Med. 2012. PMID: 21972825 Review.
-
Advances in the genetically complex autoinflammatory diseases.Semin Immunopathol. 2015 Jul;37(4):403-6. doi: 10.1007/s00281-015-0498-0. Epub 2015 Jun 16. Semin Immunopathol. 2015. PMID: 26077134 Free PMC article. Review.
-
Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.Rheum Dis Clin North Am. 2017 Aug;43(3):327-345. doi: 10.1016/j.rdc.2017.04.011. Rheum Dis Clin North Am. 2017. PMID: 28711137 Free PMC article. Review.
-
Autoinflammatory disorders, pain, and neural regulation of inflammation.Dermatol Clin. 2013 Jul;31(3):461-70. doi: 10.1016/j.det.2013.04.002. Epub 2013 May 14. Dermatol Clin. 2013. PMID: 23827248 Review.
Cited by
-
NLRP12-associated autoinflammatory disease in Chinese adult patients: a single-centre study.RMD Open. 2023 Dec 20;9(4):e003598. doi: 10.1136/rmdopen-2023-003598. RMD Open. 2023. PMID: 38123482 Free PMC article. Review.
-
[Glycosylphosphatidylinositol biosynthesis deficiency 15 caused by GPAA1 gene mutation: a rare disease study].Zhongguo Dang Dai Er Ke Za Zhi. 2023 Dec 15;25(12):1276-1281. doi: 10.7499/j.issn.1008-8830.2307114. Zhongguo Dang Dai Er Ke Za Zhi. 2023. PMID: 38112147 Free PMC article. Chinese.
-
Severe chronic non-bacterial osteomyelitis in combination with total MPO deficiency and responsiveness to TNFα inhibition.Front Immunol. 2023 Oct 26;14:1233101. doi: 10.3389/fimmu.2023.1233101. eCollection 2023. Front Immunol. 2023. PMID: 37954595 Free PMC article.
-
Case Report: A de novo NLRP3 variant resulting in autoinflammatory disease in a Chinese newborn.Front Immunol. 2023 Oct 3;14:1238551. doi: 10.3389/fimmu.2023.1238551. eCollection 2023. Front Immunol. 2023. PMID: 37854599 Free PMC article.
-
Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study.Pediatr Rheumatol Online J. 2023 Oct 17;21(1):124. doi: 10.1186/s12969-023-00881-0. Pediatr Rheumatol Online J. 2023. PMID: 37848905 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous